Study of serum magnesium levels in Type 2 Diabetes mellitus at tertiary medical centre, Karnataka, India

Authors

  • Vidya Baleguli K.S.Hegde Medical Academy
  • Kishan Prasad HL
  • Kishan Prasad HL
  • U Sanjana Rao
  • U Sanjana Rao
  • Chandrika Rao
  • Chandrika Rao
  • Suchetha Kumari
  • Suchetha Kumari

Keywords:

Correlations, Fasting blood sugar, Serum magnesium, Type 2 diabetes, Post prandial blood sugar.

Abstract

Background: Diabetes and poor glycaemic control alters the metabolism of magnesium (Mg) by increasing their urinary excretion and lowering serum Mg levels. Low serum Mg levels will contribute to the evolution of diabetic complications such as retinopathy, abnormal platelet function, cardiovascular disease and hypertension via reduction in the rate of inositol transport and subsequent intracellular depletion. This study aimed at evaluation of serum Mg levels with Type 2 diabetics and control non diabetic individuals.

Methods:  After the Ethical approval, blood samples from recruited subjects (50 diabetics and 50 non diabetics) were collected and estimation of Mg in serum by xylidyl blue method, Fasting blood sugar (FBS) and post prandial blood sugar (PPBS) by Glucose oxidase peroxidase (GOD-PAP) method was done. Descriptive statistics mean and standard deviation, independent sample ’t’ test, level of significance 5% were used for analysis.

Result:  Mean value of FBS in control group of 100.98mg/dL and in case group with 134.80mg/dL. Mean value of PPBS in control group of 108.76mg/dL and in case group with 236.6mg/dL. Mean value of serum Mg in control group was 1.64mmol/L while in case group=1.20mmol/L. Serum magnesium was significantly decreased (p<0.001) in diabetics than controls. A negative linear relationship (p<0.05) between, Mg and FBS (r=-0.198 and p=0.048), Mg and PPBS (r=-0.206 and p=0.040) was found.

Conclusion: The present findings demonstrate the imbalance in levels of serum Mg among the patients of type 2 DM in comparison to controls.  Since serum magnesium is easily and inexpensively measured, and as oral magnesium replacement is cheap and safe, there is an argument for screening of diabetic patients for hypomagnesaemia and institution of supplementation if it is detected.

References

1) Jiancheng Xu, Wei Xu, Hanxin Yao, Weixia Sun, Qi Zhou, Lu Cai. Associations of serum and urinary magnesium with the pre-diabetes, Diabetes and diabetic complications in the chinese northeast population. PLoS ONE 2013; 8(2):e56750.

2) Salem M, Kholoussi S, Κholoussi N, Fawzy R. Malondialdehyde and trace element levels in patients with type 2 diabetes mellitus. Arch Hellen Med 2011; 28(1):83-8.

3) Cavalot F, Petrelli A, Traversa M, Bonomo K, Fiora E, Conti M, et al. Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: Lessons from the San Luigi Gonzaga Diabetes Study. J Clin Endocrinol Metab 2006; 91:813-9.

4) Ankush RD, Suryakar AN, Ankush NR. Hypomagnesaemia in Type-2 Diabetes Mellitus Patients: A study on the status of oxidative and nitrosative stress. Indian J Clin Biochem 2009; 24(2):184-9.

5) Dong JY, Xun P, He K, Qin LQ. Magnesium intake and risk of Type 2 diabetes: Meta-analysis of prospective cohort studies. Diabetes Care 2011; 34(9):2116-22.

6) Meenakshi Puri, Uma Gujral, Nayyar SB. Comparative study of serum Zinc, Magnesium and Copper levels among patients of type 2 Diabetes mellitus with and without Microangiopathic complications. Innovative Journal of Medical and Health Science 2013; 3(6):274 -8.

7) Song Y, He K, Levitan EB, Manson JE, Liu S. Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta-analysis of randomized double-blind controlled trials. Diabetic Med 2006; 23(10):1050-6.

8) Peters KE, Chubb SA, Davis WA, Davis TM. The relationship between hypomagnesaemia, metformin therapy and cardiovascular disease complicating type 2 diabetes: The Fremantle Diabetes Study. PLoS ONE 2013; 8(9):e74355.

9) Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FL. Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Arch 1999; 159(18):2151-9.

10) Supriya, Mohanty S, Pinnelli VB, Murgod R, Raghavendra DS. Evaluation of serum copper, magnesium and glycated haemoglobin in Type 2 Diabetes mellitus. Asian J Pharm Clin Res 2013; 6(2):188-90.

11) Gandhe MB, Jain K, Gandhe SM. Evaluation of 25(OH) Vitamin D3 with reference to magnesium status and insulin resistance in T2DM. J Clin Diagn Res 2013; 7(11):2438-41.

12) Kundu D, Osta M, Mandal T, Bandyopadhyay U, Ray D, Gautam D. Serum magnesium levels in patients with diabetic retinopathy. Nat Sci Biol Med 2013; 4(1):113-6.

13) Naidu MP, Shiva Kumar, Vali SM, Madhav D, Subrahmanyam G. Study of the role of copper, zinc and magnesium in diabetic nephropathy. RJPBCS 2013; 4(4):71.

14) Mane M, Gunwant RC, Reddy EP. Hypomagnesaemia in diabetic patients and biochemical action on the cardiovascular system. Int J Biol Med Res 2012; 3(1): 1273-6.

15) Khubchandani AS, Sanghani H. Study of serum magnesium and HbA1C in diabetic patients along with changes in their lipid profiles. Indian Journal of Clinical Practice 2013; 23:11.

16) Sharif M, Baig A, Sugoor M, Sarwari KN. Serum HS-CRP and magnesium in type 2 diabetic patients without and with complications. International Journal of Basic and Applied Medical Sciences 2013; 3(3):218-28.

17) Kulkarni AG, Shendge SK, Shinde V. Study of serum magnesium levels in Type 2 Diabetes mellitus. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) 2014; 13(4):115-9.

Downloads

Published

11-10-2016

How to Cite

1.
Baleguli V, Prasad HL K, Prasad HL K, Rao US, Rao US, Rao C, et al. Study of serum magnesium levels in Type 2 Diabetes mellitus at tertiary medical centre, Karnataka, India. Ann of Pathol and Lab Med [Internet]. 2016 Oct. 11 [cited 2025 Feb. 6];3(4):A284-288. Available from: https://pacificejournals.com/journal/index.php/apalm/article/view/apalm601

Issue

Vol. 3 No. 4 (2016)

Section

Original Article

License

Copyright (c) 2016 Vidya Baleguli, Kishan Prasad HL, Kishan Prasad HL, U Sanjana Rao, U Sanjana Rao, Chandrika Rao, Chandrika Rao, Suchetha Kumari, Suchetha Kumari

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access at http://opcit.eprints.org/oacitation-biblio.html).